BidaskClub Downgrades Exactech (EXAC) to Sell

Exactech (NASDAQ:EXAC) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday.

Several other equities research analysts have also issued reports on EXAC. Sidoti lowered shares of Exactech from a “buy” rating to a “neutral” rating in a research report on Monday, October 23rd. ValuEngine lowered shares of Exactech from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Robert W. Baird reissued a “hold” rating and issued a $49.00 price objective on shares of Exactech in a research report on Thursday, December 7th. Gabelli lowered shares of Exactech from a “buy” rating to a “hold” rating in a research report on Tuesday, October 24th. Finally, Zacks Investment Research raised shares of Exactech from a “sell” rating to a “hold” rating in a research report on Tuesday, December 26th. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the company. The stock has an average rating of “Hold” and an average target price of $49.00.

Shares of Exactech (NASDAQ EXAC) opened at $49.25 on Thursday. Exactech has a 52-week low of $23.75 and a 52-week high of $50.95. The stock has a market cap of $710.38, a price-to-earnings ratio of 2,462.50, a PEG ratio of 3.66 and a beta of 0.90. The company has a quick ratio of 2.09, a current ratio of 4.08 and a debt-to-equity ratio of 0.06.

Several institutional investors have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company increased its position in shares of Exactech by 3.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider’s stock worth $278,000 after acquiring an additional 289 shares in the last quarter. Teachers Advisors LLC grew its holdings in Exactech by 2.7% during the 2nd quarter. Teachers Advisors LLC now owns 21,549 shares of the medical equipment provider’s stock valued at $642,000 after purchasing an additional 568 shares in the last quarter. California Public Employees Retirement System grew its holdings in Exactech by 4.5% during the 2nd quarter. California Public Employees Retirement System now owns 23,100 shares of the medical equipment provider’s stock valued at $688,000 after purchasing an additional 1,000 shares in the last quarter. First Trust Advisors LP grew its holdings in Exactech by 13.4% during the 4th quarter. First Trust Advisors LP now owns 9,516 shares of the medical equipment provider’s stock valued at $471,000 after purchasing an additional 1,128 shares in the last quarter. Finally, Alliancebernstein L.P. grew its holdings in Exactech by 6.1% during the 2nd quarter. Alliancebernstein L.P. now owns 24,456 shares of the medical equipment provider’s stock valued at $729,000 after purchasing an additional 1,400 shares in the last quarter. 61.22% of the stock is owned by institutional investors.

WARNING: “BidaskClub Downgrades Exactech (EXAC) to Sell” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://ledgergazette.com/2018/02/17/bidaskclub-downgrades-exactech-exac-to-sell.html.

Exactech Company Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply